Concepedia

Anja Jünger

AJ

3

Publications

99

Citations

3

H-Index

2014

Active since

Affiliations

Heidelberg University(Current)

German Cancer Research Center

Anja Jünger is an author at Heidelberg University specializing in medicine, pharmacology, and translational medicine.

Top concepts

LiverMedicineHepatitisHepatologyImmunologyEngineeringCell BiologyInflammationPharmacologyCell Signaling

Publications per year

2014–2017

3

Publications

3

Detailed analysis of pro-apoptotic signaling and metabolic adaptation triggered by a N-heterocyclic carbene–gold(<scp>i</scp>) complex

Pavlo Holenya, Suzan Can, Riccardo Rubbiani et al. · Metallomics · 2014 · 60 citations · Full text

Model Based Targeting of IL-6-Induced Inflammatory Responses in Cultured Primary Hepatocytes to Improve Application of the JAK Inhibitor Ruxolitinib

Svantje Sobotta, Andreas Raue, Xiaoyun Huang et al. · Frontiers in Physiology · 2017 · 28 citations · Full text

Cultured Primary, Engineering, Jak Inhibitor Ruxolitinib +25

Time course decomposition of cell heterogeneity in TFEB signaling states reveals homeostatic mechanisms restricting the magnitude and duration of TFEB responses to mTOR activity modulation

Paula Andrea Marin Zapata, Carsten Jörn Beese, Anja Jünger et al. · BMC Cancer · 2016 · 11 citations · Full text

Rows per page

1–3 of 3